We are live on ! Find out more
RPTX

Repare Therapeutics

Delisted

RPTX was delisted on the 27th of January, 2026.

66 hedge funds and large institutions have $708M invested in Repare Therapeutics in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $1.93M | Put options by funds: $627K

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

8% more funds holding

Funds holding: 6166 (+5)

0.89% more ownership

Funds ownership: 71.73%72.63% (+0.89%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

15% less capital invested

Capital invested by funds: $828M → $708M (-$121M)

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

Holders
66
Holders Change
+5
Holders Change %
+8.2%
% of All Funds
1.16%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
13
Increased
19
Reduced
23
Closed
6
Calls
$1.93M
Puts
$627K
Net Calls
+$1.31M
Net Calls Change
+$1.06M
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$1.03M +$1.27M +39,241 New
HS
27
HighVista Strategies
Massachusetts
$947K +$1.17M +36,104 New
Vanguard Group
28
Vanguard Group
Pennsylvania
$920K +$41K +1,270 +4%
JP Morgan Chase
29
JP Morgan Chase
New York
$750K +$865K +26,765 +1,496%
SG Americas Securities
30
SG Americas Securities
New York
$702K +$865K +26,767 New
State Street
31
State Street
Massachusetts
$698K +$372K +11,506 +76%
Citigroup
32
Citigroup
New York
$664K -$83.3K -2,579 -9%
Bank of America
33
Bank of America
North Carolina
$615K +$600K +18,570 +383%
PVI
34
Pura Vida Investments
New York
$581K -$941K -29,128 -57%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$561K
Swiss National Bank
36
Swiss National Bank
Switzerland
$546K
LGM
37
Logos Global Management
California
$525K -$10M -310,000 -94%
Ensign Peak Advisors
38
Ensign Peak Advisors
Utah
$509K
Renaissance Technologies
39
Renaissance Technologies
New York
$441K -$116K -3,600 -18%
Northern Trust
40
Northern Trust
Illinois
$415K +$7.53K +233 +1%
SM
41
SG3 Management
Puerto Rico
$394K +$485K +15,000 New
TI
42
Trexquant Investment
Connecticut
$381K +$469K +14,516 New
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$332K
HP
44
Harbourvest Partners
Massachusetts
$322K -$79.8K -2,471 -17%
CM
45
Caption Management
Oklahoma
$315K +$388K +12,000 New
Blackstone Inc
46
Blackstone Inc
New York
$311K +$382K +11,837 New
JF
47
Jump Financial
Illinois
$291K +$359K +11,100 New
E
48
Ergoteles
New York
$278K +$342K +10,602 New
Mitsubishi UFJ Asset Management
49
Mitsubishi UFJ Asset Management
Japan
$236K +$7.85K +243 +3%
ProShare Advisors
50
ProShare Advisors
Maryland
$208K +$41.3K +1,280 +19%

RPTX Hedge Fund Activity: Q3 2021 in Review

66 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2021, worth a combined $708M — down 15% from $828M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new RPTX positions and 6 closed out — a net gain of 7 holders — while 19 added to existing stakes and 23 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $30.4M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $11.3M sold.

  • 66 institutional investors held Repare Therapeutics (RPTX) as of Q3 2021, up from 61 in Q2 2021.
  • Funds reported $708M of Repare Therapeutics stock for Q3 2021, down 15% quarter-over-quarter.
  • 13 funds opened new Repare Therapeutics positions in Q3 2021 and 6 closed out, a net change of +7 holders.
  • The largest Repare Therapeutics buyer in Q3 2021 was ARK Investment Management, an estimated $30.4M added.
  • The largest Repare Therapeutics seller in Q3 2021 was Cormorant Asset Management, an estimated $11.3M sold.

Based on aggregated 13F filings for Q3 2021.